Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Aagaard

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Molecular Therapy. Nucleic Acids|March 31, 2022
<i>VEGFA</i>-targeting miR-agshRNAs combine efficacy with specificity and safety for retinal gene therapySidsel Alsing, Thomas Koed Doktor, Anne Louise Askou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 16, 2021
Single AAV-mediated CRISPR-Nme2Cas9 efficiently reduces mutant hTTR expression in a transgenic mouse model of transthyretin amyloidosisJinkun Wen, Tianqi Cao, Jinni Wu, et al.
RNA (New York, N.Y.)|December 24, 2005
The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cellsMarc S Weinberg, Louisa M Villeneuve, Ali Ehsani, et al.
Molecular Therapy. Methods & Clinical Development|April 12, 2024
Subretinal AAV delivery of RNAi-therapeutics targeting <i>VEGFA</i> reduces choroidal neovascularization in a large animal modelSilja Hansen Haldrup, Bjørn K Fabian-Jessing, Thomas Stax Jakobsen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 29, 2022
An Extended PD-L2 Cytoplasmic Domain Results From Alternative Splicing in NSCLC CellsLisa Loksø Dietz, Natasja Toft Furman, Trine Vilsbøll Larsen, et al.
Journal of Inherited Metabolic Disease|May 11, 2021
Variants in the ethylmalonyl-CoA decarboxylase (ECHDC1) gene: a novel player in ethylmalonic aciduria?Sarah Fogh, Graziana Dipace, Anne Bie, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|January 18, 2016
Partial correction of the dwarf phenotype by non-viral transfer of the growth hormone gene in mice: Treatment age is criticalEliza Higuti, Cláudia R Cecchi, Nélio A J Oliveira, et al.
Molecular Therapy. Nucleic Acids|February 6, 2026
AAV-mediated multiple gene therapy combining VEGFA-targeting miR-agshRNAs and PEDF for the suppression of choroidal neovascularizationBjørn K Fabian-Jessing, Anne Louise Askou, Thomas Stax Jakobsen, et al.
Molecular Therapy. Nucleic Acids|August 10, 2018
Improved Lentiviral Gene Delivery to Mouse Liver by Hydrodynamic Vector Injection through Tail VeinTrine Dalsgaard, Claudia R Cecchi, Anne Louise Askou, et al.
Tissue & Cell|April 23, 2023
Sustained secretion of human growth hormone from TheraCyte devices encapsulated with PiggyBac-engineered retinal pigment epithelium cellsClaudia R Cecchi, Sidsel Alsing, Gustavo P P Jesus, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Molecular Therapy. Nucleic Acids|March 31, 2022
<i>VEGFA</i>-targeting miR-agshRNAs combine efficacy with specificity and safety for retinal gene therapySidsel Alsing, Thomas Koed Doktor, Anne Louise Askou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 16, 2021
Single AAV-mediated CRISPR-Nme2Cas9 efficiently reduces mutant hTTR expression in a transgenic mouse model of transthyretin amyloidosisJinkun Wen, Tianqi Cao, Jinni Wu, et al.
RNA (New York, N.Y.)|December 24, 2005
The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cellsMarc S Weinberg, Louisa M Villeneuve, Ali Ehsani, et al.
Molecular Therapy. Methods & Clinical Development|April 12, 2024
Subretinal AAV delivery of RNAi-therapeutics targeting <i>VEGFA</i> reduces choroidal neovascularization in a large animal modelSilja Hansen Haldrup, Bjørn K Fabian-Jessing, Thomas Stax Jakobsen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 29, 2022
An Extended PD-L2 Cytoplasmic Domain Results From Alternative Splicing in NSCLC CellsLisa Loksø Dietz, Natasja Toft Furman, Trine Vilsbøll Larsen, et al.
Journal of Inherited Metabolic Disease|May 11, 2021
Variants in the ethylmalonyl-CoA decarboxylase (ECHDC1) gene: a novel player in ethylmalonic aciduria?Sarah Fogh, Graziana Dipace, Anne Bie, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|January 18, 2016
Partial correction of the dwarf phenotype by non-viral transfer of the growth hormone gene in mice: Treatment age is criticalEliza Higuti, Cláudia R Cecchi, Nélio A J Oliveira, et al.
Molecular Therapy. Nucleic Acids|February 6, 2026
AAV-mediated multiple gene therapy combining VEGFA-targeting miR-agshRNAs and PEDF for the suppression of choroidal neovascularizationBjørn K Fabian-Jessing, Anne Louise Askou, Thomas Stax Jakobsen, et al.
Molecular Therapy. Nucleic Acids|August 10, 2018
Improved Lentiviral Gene Delivery to Mouse Liver by Hydrodynamic Vector Injection through Tail VeinTrine Dalsgaard, Claudia R Cecchi, Anne Louise Askou, et al.
Tissue & Cell|April 23, 2023
Sustained secretion of human growth hormone from TheraCyte devices encapsulated with PiggyBac-engineered retinal pigment epithelium cellsClaudia R Cecchi, Sidsel Alsing, Gustavo P P Jesus, et al.
Pageof 5